Cytokinetics | CYTK - Gross Profit On Sales


Cytokinetics reported $19.2M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Acadia Pharmaceuticals USD 243.27M 14.49M Mar/2026
Amgen USD 6.89B 415M Dec/2025
Arca Biopharma 0 0 Mar/2025
Bayer EUR 6.94B 1.58B Dec/2025
Biogen USD 1.82B 169.5M Mar/2026
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cytokinetics USD 19.2M 1.44M Mar/2026
Eisai JPY 153.41B 15.44B Mar/2026
Eli Lilly USD 15.92B 1.33B Dec/2025
Exelixis USD 590.86M 18.68M Mar/2026
Geron USD 50.14M 3.44M Mar/2026
Halozyme Therapeutics USD 297.47M 75.53M Mar/2026
Ionis Pharmaceuticals USD 243M 48M Mar/2026
Ligand Pharmaceuticals USD 48.45M 8.22M Mar/2026
Merck USD 10.85B 2.57B Dec/2025
Novartis USD 10.07B 184M Mar/2026
Pfizer USD 11.04B 1.24B Mar/2026
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025